EEIQ vs UTI

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

EEIQ

36.6
AI Score
VS
UTI Wins

UTI

39.4
AI Score

Investment Advisor Scores

EEIQ

37score
Recommendation
SELL

UTI

39score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric EEIQ UTI Winner
Revenue 8.94M 835.62M UTI
Net Income -2.43M 63.02M UTI
Net Margin -27.2% 7.5% UTI
Operating Income -4.18M 83.47M UTI
ROE -27.6% 19.2% UTI
ROA -9.4% 7.6% UTI
Total Assets 25.78M 826.14M UTI
Cash 4.75M 127.36M UTI
Current Ratio 1.83 1.07 EEIQ
Free Cash Flow -3.24M 55.35M UTI

Relative Price Performance (Last 90 Days)

EEIQ 1M: +45.4% · 3M: +3.4% UTI 1M: -20.8% · 3M: -50.2%

Current Technical Phase

EEIQ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 73

RSI (14): 72.6 · Price: $3.62

UTI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 27

RSI (14): 26.9 · Price: $20.31

Fundamentals Snapshot

Metric EEIQ UTI
Market Cap
Forward P/E 0.0 27.6
Trailing P/E 34.9
Revenue (TTM)
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.6%
Operating Margin -0.4% 0.0%
EPS -4.17 0.59
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, UTI is currently the stronger investment candidate, winning 9 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.